CN Patent

CN101594862A — 作为激酶抑制剂的取代吲唑衍生物

Assigned to Nerviano Medical Sciences SRL · Expires 2009-12-02 · 16y expired

What this patent protects

本发明公开了如说明书中定义的式(I)的取代吲唑衍生物及其药学可接受的盐、其制备方法和包含它们的药物组合物；本发明的式(I)的化合物可用于治疗学，用于治疗与蛋白激酶活性失调有关的疾病，例如癌症。

USPTO Abstract

本发明公开了如说明书中定义的式(I)的取代吲唑衍生物及其药学可接受的盐、其制备方法和包含它们的药物组合物；本发明的式(I)的化合物可用于治疗学，用于治疗与蛋白激酶活性失调有关的疾病，例如癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN101594862A
Jurisdiction
CN
Classification
—
Expires
2009-12-02
Drug substance claim
No
Drug product claim
No
Assignee
Nerviano Medical Sciences SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.